Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
2014 · Cardiovascular Toxicology · 109 citations
https://doi.org/10.1007/s12012-014-9297-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
214
Citations
4
h-index
2
i10-index
María Sanz Fernández is an academic researcher. The author has contributed to research in topics: Sexual Differentiation and Disorders & Metabolism and Genetic Disorders & Diabetes and associated disorders. The author has an h-index of 4, co-authored 23 publications.
Click to start Chat